Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-13-041101
Filing Date
2013-11-07
Accepted
2013-11-07 16:19:52
Documents
1
Period of Report
2013-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 12536
  Complete submission text file 0001140361-13-041101.txt   14239
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 WISCONSIN CIR SUITE 660 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 660 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Reporting) CIK: 0001331693 (see all company filings)

State of Incorp.: MD | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-36066 | Film No.: 131200898